Join us for a Free Webinar on April 3

Space is limited.
Reserve your Webinar seat now at:
https://www1.gotomeeting.com/register/959191744

This live webinar has already taken place, however the archived presentation is still available for you to review
» View Presentation

Genomic Health is transitioning from RT-PCR to Next-Generation Sequencing as the basis for its development of cancer diagnostic tests. This poses both great opportunities and significant challenges.

• Learn about tests that address critical questions in cancer treatment planning
• Learn about Genomic Health's cancer mutation strategy

Genomic Health, a molecular diagnostics company, is committed to improving the quality of cancer treatment decisions through the research, development and commercialization of genomic-based clinical laboratory services. To that end, the company conducts sophisticated genomic research to develop clinically-validated molecular diagnostics which provide individualized information on response to certain types of therapy, as well as the likelihood of disease recurrence. These diagnostic technologies generate information that healthcare providers and patients can use in making treatment decisions.

Presenter:
Joffre Baker, Chief Scientific Officer, Genomic Health Inc.

Joffre Baker is Chief Scientific Officer at Genomic Health Inc. Prior to this, he was Vice President of Research Discovery at Genentech. Dr. Baker received a BS Biology & Chemistry degree at University of California, San Diego and a PhD in Biochemistry at the University of Hawaii.

After registering you will receive a confirmation email containing information about joining the Webinar.

System Requirements
PC-based attendees
Required: Windows® 7, Vista, XP or 2003 Server

Macintosh®-based attendees
Mac OS® X 10.5 or newer